Skip Navigation


Brain Advance Access originally published online on March 2, 2007
Brain 2007 130(6):1477-1484; doi:10.1093/brain/awm006
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
130/6/1477    most recent
awm006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Griggs, R.
Right arrow Articles by Udd, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griggs, R.
Right arrow Articles by Udd, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2007). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Zaspopathy in a large classic late-onset distal myopathy family

R. Griggs1, A. Vihola2, P. Hackman2, K. Talvinen3, H. Haravuori2, G. Faulkner4, B. Eymard5, I. Richard6, D. Selcen7, A. Engel7, O. Carpen3,8 and B. Udd2,9,10

1Department of Neurology, University of Rochester Medical Center, Rochester, NY, 7Department of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN, USA, 2Folkhalsan Institute of Genetics and Department of Medical Genetics, 8Neuroscience Program and Department of Pathology, University of Helsinki, Helsinki, 3Department of Pathology, University of Turku and Turku University Hospital, Turku, 9Department of Neurology, Vasa Central Hospital, Vasa, 10Department of Neurology, Tampere University Hospital, Tampere, Finland, 4Muscle Molecular Biology Unit, International Centre of Genetic Engineering and Biotechnology, Trieste, Italy, 5Institut de Myologie, Groupe Hospitalier Pitié-Salpêtrière, Paris and 6Généthon, CNRS-UMR8115, Évry, France

Corresponding to: Bjarne Udd, Folkhalsan Institute of Genetics and Department of Medical Genetics, P.O.B. 63, FIN-00014, University of Helsinki, Helsinki, Finland. E-mail: bjarne.udd{at}netikka.fi

Distal myopathies have been associated with mutations in titin, dysferlin, GNE, desmin and myosin. Of these, only titin mutations were previously known to cause dominant late-onset distal myopathy. Recent findings, however, have indicated that patients affected with myofibrillar myopathy have a more distal than proximal muscle phenotype and a proportion of these may have mutations in myotilin, ZASP or filamin C, besides previously known desmin and {alpha}B-crystallin. Here we report that the disorder in one of the well-characterized autosomal dominant distal myopathy families, the Markesbery et al. family, first reported in 1974, is caused by ZASP mutation A165V. Previous linkage to the titin locus 2q31 proved incorrect. ZASP expression by immunoblotting shows normal presence of the main 32 and 78 kDa bands and immunohistochemistry in patients reveals normal Z-disc localization except for moderate accumulations together with myotilin, desmin {alpha}B-crystallin and {alpha}-actinin. Muscle imaging reveals involvement in both the posterior and anterior compartments of the lower leg and considerable affection of proximal leg muscles at later stages. Haplotype studies in this family and in five other unrelated families with European ancestry carrying the identical A165V mutation share common markers at the locus suggesting the existence of a founder mutation.

Key Words: myofibrillar myopathy; distal myopathy; ZASP

Abbreviations: DCM, dilated cardiomyopathy; ECL, enhanced chemiluminescence; HRP, horseradish peroxidase; MFM, myofibrillar myopathies; ZASP, Z-band alternatively spliced PDZ-motif containing protein; ZM, zasp-like motif

Received December 7, 2006. Revised January 2, 2007. Accepted January 5, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
T. Arimura, N. Inagaki, T. Hayashi, D. Shichi, A. Sato, K. Hinohara, M. Vatta, J. A. Towbin, T. Chikamori, A. Yamashina, et al.
Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy
Cardiovasc Res, July 1, 2009; 83(1): 80 - 88.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Fischer, R. A. Kley, K. Strach, C. Meyer, T. Sommer, K. Eger, A. Rolfs, W. Meyer, A. Pou, J. Pradas, et al.
Distinct muscle imaging patterns in myofibrillar myopathies
Neurology, September 2, 2008; 71(10): 758 - 765.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Berciano, E Gallardo, R Dominguez-Perles, E Gallardo, A Garcia, R Garcia-Barredo, O Combarros, J Infante, and I Illa
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 205 - 208.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. A. Kley, Y. Hellenbroich, P. F. M. van der Ven, D. O. Furst, A. Huebner, V. Bruchertseifer, S. A. Peters, C. M. Heyer, J. Kirschner, R. Schroder, et al.
Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients
Brain, December 1, 2007; 130(12): 3250 - 3264.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.